BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37638717)

  • 1. Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes.
    Ozdag Acarli AN; Tuzun E; Sanli E; Koral G; Akbayir E; Cakar A; Sirin NG; Soysal A; Aysal F; Durmus H; Parman Y; Yilmaz V
    Clin Exp Immunol; 2024 Jan; 215(1):65-78. PubMed ID: 37638717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease activity in chronic inflammatory demyelinating polyneuropathy: A comparative study of clinical and skin biopsy markers.
    Acarli ANÖ; Ünverengil G; Şirin NG; Çakar A; Durmuş H; Parman Y
    Muscle Nerve; 2022 Dec; 66(6):736-743. PubMed ID: 36151750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy.
    Bozovic I; Perovic V; Basta I; Peric S; Stevic Z; Popadic D; Vukovic I; Stojanov A; Milosevic E
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of F wave changes in patients with Charcot-Marie-Tooth1A and chronic inflammatory demyelinating polyneuropathy].
    Liu XX; Zhang S; Ma Y; Sun AP; Zhang YS; Fan DS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):160-166. PubMed ID: 36718706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study.
    Hauw F; Fargeot G; Adams D; Attarian S; Cauquil C; Chanson JB; Créange A; Gendre T; Deiva K; Delmont E; Francou B; Genestet S; Kuntzer T; Latour P; Le Masson G; Magy L; Nardin C; Ochsner F; Sole G; Stojkovic T; Maisonobe T; Tard C; Van den Berghe P; Echaniz-Laguna A
    Eur J Neurol; 2021 Sep; 28(9):2846-2854. PubMed ID: 34060689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of lower extremity ultrasonographic nerve enlargement for differentiating demyelinating Charcot-Marie-Tooth disease from chronic inflammatory demyelinating polyneuropathy.
    Naito H; Sugimoto T; Hironaka A; Nakamori M; Yamazaki Y; Ochi K; Maruyama H
    J Neurol Sci; 2024 May; 460():122995. PubMed ID: 38583391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
    Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
    Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?
    Potulska-Chromik A; Ryniewicz B; Aragon-Gawinska K; Kabzinska D; Seroka A; Lipowska M; Kaminska AM; Kostera-Pruszczyk A
    J Peripher Nerv Syst; 2016 Mar; 21(1):22-6. PubMed ID: 26663344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies.
    Lee G; Xiang Z; Brannagan TH; Chin RL; Latov N
    J Neurol Sci; 2010 Mar; 290(1-2):115-22. PubMed ID: 19922956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
    Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
    Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
    Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
    Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy.
    Fisse AL; Fiegert S; Stoykova Z; Brünger J; Athanasopoulos D; Grüter T; Motte J; Gold R; Pitarokoili K
    Eur J Neurol; 2021 May; 28(5):1698-1705. PubMed ID: 33404183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP.
    Staudt M; Diederich JM; Meisel C; Meisel A; Klehmet J
    BMC Neurol; 2017 Apr; 17(1):81. PubMed ID: 28446142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy.
    Sugimoto T; Ochi K; Hosomi N; Takahashi T; Ueno H; Nakamura T; Nagano Y; Maruyama H; Kohriyama T; Matsumoto M
    J Neurol; 2013 Oct; 260(10):2580-7. PubMed ID: 23821028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-31-5p as a Potential Circulating Biomarker and Tracer of Clinical Improvement for Chronic Inflammatory Demyelinating Polyneuropathy.
    Dziadkowiak E; Baczyńska D; Wieczorek M; Olbromski M; Moreira H; Mrozowska M; Budrewicz S; Dzięgiel P; Barg E; Koszewicz M
    Oxid Med Cell Longev; 2023; 2023():2305163. PubMed ID: 37077658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
    Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
    Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.
    Tackenberg B; Nimmerjahn F; Lünemann JD
    J Clin Immunol; 2010 May; 30 Suppl 1():S65-9. PubMed ID: 20424898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal confocal microscopy detects small fiber damage in chronic inflammatory demyelinating polyneuropathy (CIDP).
    Schneider C; Bucher F; Cursiefen C; Fink GR; Heindl LM; Lehmann HC
    J Peripher Nerv Syst; 2014 Dec; 19(4):322-7. PubMed ID: 25582791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Typical CIDP: Update of the Pathogenesis, Diagnosis, and Treatment].
    Kuwabara S
    Brain Nerve; 2024 May; 76(5):515-519. PubMed ID: 38741490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.